Search research articles
Contact Us
Filters
Showing results (81-90 of 1,750) with videos related to
Page
of 175
Sort By:
European Urology
|
April 2, 2014
Metabolic syndrome as a marker for prostate cancer: still a work in progress
Andrea Gallina, Alessandro Nini, Francesco Montorsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2014
Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?
Gianluca Giannarini, Giorgio Gandaglia, Francesco Montorsi, et al.
British Journal of Cancer
|
October 26, 2016
Comment on 'Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome'
Paolo Dell'Oglio, Armando Stabile, Giorgio Gandaglia, et al.
The Journal of Urology
|
September 6, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline. Letter
Francesco Montorsi, Giorgio Gandaglia, Andrea Salonia, et al.
European Urology
|
February 4, 2018
Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
European Urology
|
January 26, 2020
Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14
Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
The Journal of Urology
|
April 10, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter
Marco Moschini, Andrea Necchi, Alberto Briganti, et al.
The Journal of Urology
|
February 8, 2024
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)
Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, et al.
BJU International
|
October 3, 2025
Re: 'Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review'
Simone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology
|
December 4, 2015
Excellent Erectile Function Recovery after Focal Therapy: Is This Enough?
Giorgio Gandaglia, Alberto Briganti, Andrea Salonia, et al.
Page
of 175
Search research articles
Search
Showing results (81-90 of 1,750) with videos related to
Sort By:
Page
of 175
European Urology
|
April 2, 2014
Metabolic syndrome as a marker for prostate cancer: still a work in progress
Andrea Gallina, Alessandro Nini, Francesco Montorsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2014
Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?
Gianluca Giannarini, Giorgio Gandaglia, Francesco Montorsi, et al.
British Journal of Cancer
|
October 26, 2016
Comment on 'Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome'
Paolo Dell'Oglio, Armando Stabile, Giorgio Gandaglia, et al.
The Journal of Urology
|
September 6, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline. Letter
Francesco Montorsi, Giorgio Gandaglia, Andrea Salonia, et al.
European Urology
|
February 4, 2018
Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
European Urology
|
January 26, 2020
Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14
Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
The Journal of Urology
|
April 10, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter
Marco Moschini, Andrea Necchi, Alberto Briganti, et al.
The Journal of Urology
|
February 8, 2024
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)
Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, et al.
BJU International
|
October 3, 2025
Re: 'Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review'
Simone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology
|
December 4, 2015
Excellent Erectile Function Recovery after Focal Therapy: Is This Enough?
Giorgio Gandaglia, Alberto Briganti, Andrea Salonia, et al.
Page
of 175